Spero Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $3,048 | $11,802 | $5,874 | $15,044 |
Gross Profit | 3,048 | 11,802 | -7,732 | -79,590 |
EBITDA | -7,382 | -2,361 | -14,555 | -20,848 |
EBIT | -14,556 | -20,754 | ||
Net Income | -7,382 | -1,700 | -13,866 | -20,888 |
Net Change In Cash | 3,048 | 11,802 | 5,874 | 15,044 |
Free Cash Flow | 17,422 | -17,693 | -4,002 | -23,401 |
Cash | 48,616 | 31,194 | 48,887 | 52,889 |
Basic Shares | 56,280 | 56,026 | 55,376 | 54,037 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $47,977 | $103,781 | $48,579 | $3,070 |
Gross Profit | -48,780 | 52,341 | 48,579 | 3,070 |
EBITDA | -72,482 | 27,154 | -42,941 | -87,170 |
EBIT | -72,484 | 26,787 | -43,810 | -87,816 |
Net Income | -68,566 | 22,806 | -46,415 | -89,756 |
Net Change In Cash | 47,977 | 103,781 | 48,579 | 3,070 |
Free Cash Flow | -23,444 | -32,995 | -7,731 | -64,308 |
Cash | 52,889 | 76,333 | 109,107 | 112,584 |
Basic Shares | 54,037 | 52,989 | 37,585 | 30,895 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.13 |
2025-06-30 | -$0.03 |
2025-03-31 | -$0.24 |
2024-12-31 | -$0.36 |
